0

Alcaftadine

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP147084104
CAS147084-10-4
Structure
MDL NumberMFCD09954106
Molecular Weight307.39
InChI KeyMWTBKTRZPHJQLH-UHFFFAOYSA-N
Description≥98% (HPLC)
SolubilityDMSO: 5 mg/mL, clear (warmed)
Assay≥98% (HPLC)
Colorwhite to light brown
Formpowder
Size10MG, 50MG
Storage Conditions2-8°C
1

Alcaftadine 0.25% Versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study

Hiroshi Nakatani, Paul Gomes, Ron Bradford, Qiang Guo, Eleonora Safyan, David A Hollander

Ocul Immunol Inflamm. 2019;27(4):622-631.

PMID: 29543548

1

Comparison of Cytotoxicities and Anti-Allergic Effects of Topical Ocular Dual-Action Anti-Allergic Agents

Sung Il Kim, Choul Yong Park, Gladys Fordjuor, Jong Heon Lee, Jong Soo Lee, Ji Eun Lee

BMC Ophthalmol. 2019 Nov 8;19(1):217.

PMID: 31703568

1

Histamine and H1-antihistamines: Celebrating a Century of Progress

F Estelle R Simons, Keith J Simons

J Allergy Clin Immunol. 2011 Dec;128(6):1139-1150.e4.

PMID: 22035879

1

Topical Antihistamines, Mast Cell Stabilizers, and Dual-Action Agents in Ocular Allergy: Current Trends

Hadas Ben-Eli, Abraham Solomon

Curr Opin Allergy Clin Immunol. 2018 Oct;18(5):411-416.

PMID: 30020258

1

Topical Olopatadine in the Treatment of Allergic Conjunctivitis: A Systematic Review and Meta-analysis

Ka Wai Kam, Li Jia Chen, Noel Wat, Alvin L Young

Ocul Immunol Inflamm. 2017 Oct;25(5):663-677.

PMID: 27192186

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode